The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Ucb Biopharma competitive analysis

Loading summary...

Latest oppositions filed by Ucb Biopharma

Explore patent oppositions filed by Ucb Biopharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2784084
Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofGENENTECHApr 23, 2020
EP2531218
Immunoglobulin PreparationCSL BEHRINGSep 11, 2019
EP2282758
Antibodies And Vaccines For Use In Therapeutic And Diagnostic Methods For Alpha-Synuclein-Related DisordersBIOARCTICAug 21, 2019
EP2144613
Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSSIFI MABDec 21, 2018
EP2606142
Method For Inactivating Proteases By Ph Change In A Liquid Obtained From A Cell CultureBOEHRINGER INGELHEIMNov 28, 2018
EP2586788
Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHAug 29, 2018
EP2794652
Rapid Method For Cloning And Expression Of Cognate Antibody Variable Region Gene SegmentsF HOFFMANN LA ROCHEAug 15, 2018

Latest patents of Ucb Biopharma opposed by its competitors

Explore Ucb Biopharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3630946
Mar 27, 2024Cell Culture Methods4
EP3717631
Aug 30, 2023Cell Culture Methods2
EP3311168
May 10, 2023Novel Tnf Structure For Use In Therapy1
EP2515887
Jun 6, 2018Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine2
EP2922533
Jun 14, 2017Multi-Day Patch For The Transdermal Administration Of Rotigotine2

Latest PTAB cases involving Ucb Biopharma

Discover the latest PTAB cases involving Ucb Biopharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 15, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Ucb Biopharma

IPR2019-00400Dec 13, 2018APOTEXUCB BIOPHARMAFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Ucb Biopharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UCB BIOPHARMA SPRL - 5 - -
AMW32 - -
DR H ULRICH DORRIES26 - - -
GENERICS UK214 - - -